Sentence examples for dialysis analysis from inspiring English sources

The method described here allows real time detection of the drug release rate, in contrast to common dialysis analysis.

Given uncertainty whether the entered SCr was obtained pre- or post-dialysis, analysis was repeated using a single adjusted value for SCr of either 4.0 or 5.0 mg/dL.

In in vitro release, determined by a dialysis technique, analysis showed that uncoupled SLNs exhibited higher drug release as compared to coupled SLNs.

MJ Oliver is the co-creator of the Dialysis Measurement Analysis and Reporting System.

To minimize the potential for including acute renal failure or only including a healthier population of ESRD patients on dialysis, the analysis presented here utilizes specific codes that are only utilized by ESRD patients on dialysis.

Although the best-available published evidence was used to model costs and benefits associated with increasing PD use among incident patients with ESRD requiring dialysis, the analysis has several limitations.

In multivariate analysis, dialysis was the only significant risk factor, OR 6.35 [IC95 1.76–22.9] (p = 0.005).

This group represented retrospective data and was matched a priori for approximate age and prior duration of chronic dialysis before the analysis was run.

This dialysis also permitted analysis of the platelet and chylomicron fractions for brevetoxin binding, and approximately 25% of the binding was to platelets and 2.5% was to the chylomicron fractions.

Dispersions were evaluated by dynamic light-scattering for zeta-average diameter (Dz) and zeta-potential analysis; dialysis for determination of drug entrapment efficiency; plating and CFU counting for determination of cell viability of Mycobacterium smegmatis or tuberculosis, minimal bactericidal concentration (MBC) and synergism index for DODAB/drug combinations.

In intermittent dialysis, a meta-analysis of 11 randomized studies in patients with end-stage renal failure found no difference between unfractionated heparin and low-molecular-weight heparin in terms of bleeding complications or antithrombotic efficacy [96].